Hyperprolactinaemia and verapamil: Prevalence and potential association with hypogonadism in men

Clinical Endocrinology

Volumn 45, Issue 5, 1996, Pages 571-575

  Romeo, June H ^d   Dombrowski, Robert ^b   Kwak, Yun S ^c   Fuehrer, Susan ^d   Aron, David C ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b Baltimore VA Healthcare System   (United States)

^c Ajou University School of Medicine   (South Korea)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; TESTOSTERONE; VERAPAMIL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029796527     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.00859.x     Document Type: Article

References (19)

1. Aron, D.C., Tyrrell, J.B. & Wilson, C.B. (1995) Current concepts in diagnosis and management of pituitary tumors. Western Journal of Medicine, 162, 340-352.
2. Biller, B.M.K., Baum, H.B.A., Rosenthal, D.I., Saxe, V.C., Charpie, P.M. & Klibanski, A. (1992) Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. Journal of Clinical Endocrinology and Metabolism, 75, 692-697.
3. Carter, J.N., Tyson, J.E., Tolls, G., Van Vleet, S., Faiman, C. & Friesen, H.G. (1978) Prolactin-secreting tumors and hypogonadism in 22 men. New England Journal of Medicine, 299, 847-852.
4. Dombrowski, R., Romeo, J.H. & Aron, D.C. (1995) Verapamilinduced hyperprolactinaemia complicated by a pituitary incidentaloma. Annals of Pharmacotherapy, 29, 999-1001.
5. Dupuy, M., Derome, P.J., Peillon, F., Jedynak, C.P., Visot, A., Racadot, J. & Guiot, G. (1984) L'Adenome a prolactine chez l'homme: etude pre- et post-operartoire de quatre-vingts cas. Semaine Hopital Paris, 60, 2943-2954.
6. Fearrington, E.L., Rand, C.H. & Rose, J.D. (1983) Hyperprolactinaemia-galactorrhea induced by verapamil. American Journal of Cardiology, 51, 145-46.
7. Gluskin, L.E., Strasberg, B. & Shah, J.H. (1981) Verapamil-induced hyperprolactinaemia and galactorrhea. Annals of Internal Medicine, 95, 66-67.
8. Gray, A., Berlin, J.A., McKinlay, J.B. & Longcope, C. (1991) An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. Journal of Clinical Epidemiology, 44, 671-684.
9. Jackson, J.A., Riggs, M.W. & Spiekerman, A.M. (1992) Testosterone deficiency a risk factor for hip fractures in men: a case control study. American Journal of Medical Sciences, 304, 4-8.
10. Kamal, T.J. & Molitch, M.E. (1992) Effects of calcium channel blockade with verapamil on the prolactin responses to TRH, L-dopa, and bromocriptine. American Journal of Medical Sciences, 304, 289-293.
11. Kelley, S.R., Kamal, T.J. & Molitch, M.E. (1996) Mechanism of verapamil calcium channel blockade-induced hyperprolactinaemia. American Journal of Physiology, 270 (Endocrinology Metabolism, 33), E96-E100.
12. Klibanski, A. & Zervas, N.T. (1991) Diagnosis and management of hormone-secreting pituitary adenomas. New England Journal of Medicine, 324, 822-31.
13. Knoepfelmacher, M., Villares, S.M., Nicdau, W., Germek, O.O., Larario, A.C., Wajchtenberg, B.L. & Liberman, B. (1994) Calcium and prolactin secretion in humans: effects of the channel blocker, verapamil, in the spontaneous and drug induced hyperprolactinaemia. Hormonal and Metabolic Research, 26, 481-5.
14. Leite, V., Cosby, H., Sobrinho, L.G., Fresnoza, A., Santos, M.A. & Friesen, H.G. (1992) Characterization of big prolactin in patients with hyperprolactinaemia. Clinical Endocrinology, 37, 365-372.
15. Lindstedt, G. (1994) Endogenous antibodies against prolactin - a 'new' cause of hyperprolactinaemia. European Journal of Endocrinology, 130, 429-432.
16. Miyai, K., Ichihara, K., Kondo, K. & Mori, S. (1986) Asymptomatic hyperprolactinaemia and prolactinoma in the general population - mass screening by paired assays of serum prolactin. Clinical Endocrinology, 25, 549-554.
17. Pickar, D., Wolkowitz, O.M., Doran, A.R., Labarca, R., Roy, A., Breier, A. & Narang, P.K. (1987) Clinical and biochemical effects of verapamil administration to schizophrenic patients. Archives of General Psychiatry, 44, 113-118.
18. Randall, R.V., Laws, E.R. Jr., Abboud, C.F., Ebersold, M.J., Kao, P.C. & Scheithauer, B.W. (1983) Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Results in 100 patients. Mayo Clinic Proceedings, 58, 108-121.
19. Schlechte, J., Walkner, L. & Kathol, M. (1992) A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinaemia. Journal of Clinical Endocrinology and Metabolism, 75, 698-703.